Anti cancer drugs

Lanib 250mg tablet (Lapatinib) belongs to class of anti-neoplastic drugs which prevents the development and spreading of cancer cells all over the body, Lanib is indicated for metastatic breast cancer and spreading after using of other chemotherapy drugs.

Lanib belongs to class of anti-neoplastic drugs which prevents the development and spreading of cancer cells all over the body.

Lanib is indicated for metastatic breast cancer and spreading after using of other chemotherapy drugs

Product Details

Trade name :Lanib

Active component : Lapatinib

Strength :250 mg

Manufactured by :Novartis

Packing: 120 Tablets

Mechanism Of Action

Lanib is a type of classification called kinase inhibitor and act by intracellular tyrosine kinase.

Lanib prohibits ErbB-forced tumor cell growth in vitro and in various animal models. When combination 5-fluracil with Lanib created an additive effect in the 4 tumor cell lines tested. Development inhibitsthe Lanib tablet effect were examined in trastuzumab-conditioned cell lines.

Lanib provide selective action against breast cancer cell lines selected for long-term growth in trastuzumab-containing intracellularly. Hormone receptor-positive breast cancer cells (with ER [Estrogen Receptor] and/or PgR [Progesterone Receptor]) that co express the HER2 bear to be protection against established endocrine therapies. Simultaneously hormone receptor-positive breast cancer cells that initially lack EGFR or HER2 unrecalled these receptor proteins as the tumor becomes resistant to endocrine therapy.